Quizartinib in Combination With FLAG-IDA for Relapsed or Refractory Acute Myeloid Leukemia (FLAG-QUIDA): A PETHEMA Phase I-II Trial.

Bernal T, Zambrano Márquez J, Rodríguez-Veiga R, Rodríguez-Arbolí E, Bergua-Burgués JM, Vives S, Arnán M, Martínez Sánchez P, Herrera-Puente P, Serrano-López J, Rubio V, Marchante-Cepillo I, Cervera-Calvo M, Novo García A, Fernández Martín R, Gil Cortés C, Rodríguez-Medina C, Noriega-Concepción V, Alfonso-Piérola A, Loredo C, Antuña-Casal M, Boluda B, Cano-Ferri I, Acuña-Cruz E, Torres-Miñana L, Sánchez-García J, Bilbao C, Gómez-Casares MT, Martínez Cuadrón D, Montesinos P

Open source

DOI: 10.1002/ajh.70424
Published: 2026 Sep
Container: American journal of hematology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ajh.70424,
  title = {Quizartinib in Combination With FLAG-IDA for Relapsed or Refractory Acute Myeloid Leukemia (FLAG-QUIDA): A PETHEMA Phase I-II Trial.},
  author = {Bernal T and Zambrano Márquez J and Rodríguez-Veiga R and Rodríguez-Arbolí E and Bergua-Burgués JM and Vives S and Arnán M and Martínez Sánchez P and Herrera-Puente P and Serrano-López J and Rubio V and Marchante-Cepillo I and Cervera-Calvo M and Novo García A and Fernández Martín R and Gil Cortés C and Rodríguez-Medina C and Noriega-Concepción V and Alfonso-Piérola A and Loredo C and Antuña-Casal M and Boluda B and Cano-Ferri I and Acuña-Cruz E and Torres-Miñana L and Sánchez-García J and Bilbao C and Gómez-Casares MT and Martínez Cuadrón D and Montesinos P},
  year = {2026},
  journal = {American journal of hematology},
  doi = {10.1002/ajh.70424},
  url = {https://doi.org/10.1002/ajh.70424}
}

RIS

TY  - JOUR
TI  - Quizartinib in Combination With FLAG-IDA for Relapsed or Refractory Acute Myeloid Leukemia (FLAG-QUIDA): A PETHEMA Phase I-II Trial.
AU  - Bernal T
AU  - Zambrano Márquez J
AU  - Rodríguez-Veiga R
AU  - Rodríguez-Arbolí E
AU  - Bergua-Burgués JM
AU  - Vives S
AU  - Arnán M
AU  - Martínez Sánchez P
AU  - Herrera-Puente P
AU  - Serrano-López J
AU  - Rubio V
AU  - Marchante-Cepillo I
AU  - Cervera-Calvo M
AU  - Novo García A
AU  - Fernández Martín R
AU  - Gil Cortés C
AU  - Rodríguez-Medina C
AU  - Noriega-Concepción V
AU  - Alfonso-Piérola A
AU  - Loredo C
AU  - Antuña-Casal M
AU  - Boluda B
AU  - Cano-Ferri I
AU  - Acuña-Cruz E
AU  - Torres-Miñana L
AU  - Sánchez-García J
AU  - Bilbao C
AU  - Gómez-Casares MT
AU  - Martínez Cuadrón D
AU  - Montesinos P
PY  - 2026
JO  - American journal of hematology
DO  - 10.1002/ajh.70424
UR  - https://doi.org/10.1002/ajh.70424
ER  -

APA

T, B., J, Z. M., R, R., E, R., JM, B., S, V., M, A., P, M. S., P, H., J, S., V, R., I, M., M, C., A, N. G., R, F. M., C, G. C., C, R., V, N., A, A., C, L., M, A., B, B., I, C., E, A., L, T., J, S., C, B., MT, G., D, M. C., & P, M. (2026). Quizartinib in Combination With FLAG-IDA for Relapsed or Refractory Acute Myeloid Leukemia (FLAG-QUIDA): A PETHEMA Phase I-II Trial.. American journal of hematology. https://doi.org/10.1002/ajh.70424

Source records

pubmed · retrieved 2026-09-26T02:01:31.074Z